Asymmetric Cell Division and Tumor Heterogeneity

Asymmetric cell division (ACD) gives rise to two daughter cells with different fates after mitosis and is a fundamental process for generating cell diversity and for the maintenance of the stem cell population. The cancer stem cell (CSC) theory suggests that CSCs with dysregulated self-renewal and asymmetric cell division serve as a source of intra-tumoral heterogeneity. This heterogeneity complicates the diagnosis and treatment of cancer patients, because CSCs can give rise to aggressive clones that are metastatic and insensitive to multiple drugs, or to dormant tumor cells that are difficult to detect. Here, we review the regulatory mechanisms and biological significance of asymmetric division in tumor cells, with a focus on ACD-induced tumor heterogeneity in early tumorigenesis and cancer progression. We will also discuss how dissecting the relationship between ACD and cancer may help us find new approaches for combatting this heterogeneity.

Automated summary

Asymmetric cell division is a fundamental process for generating cell diversity and maintaining stem cell populations. In tumor cells, asymmetric division is closely associated with cancer initiation and progression, leading to intratumoral heterogeneity. Studying the relationship between ACD and cancer may provide new approaches for combating cancer heterogeneity.